Review



integrin subunit β6  (Bioss)


Bioz Verified Symbol Bioss is a verified supplier
Bioz Manufacturer Symbol Bioss manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Bioss integrin subunit β6
    Integrin Subunit β6, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 22 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/integrin subunit β6/product/Bioss
    Average 94 stars, based on 22 article reviews
    integrin subunit β6 - by Bioz Stars, 2026-05
    94/100 stars

    Images



    Similar Products

    integrin subunit β6  (Bioss)
    94
    Bioss integrin subunit β6
    Integrin Subunit β6, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/integrin subunit β6/product/Bioss
    Average 94 stars, based on 1 article reviews
    integrin subunit β6 - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    1:100 mouse anti-human β6 integrin subunit antibody  (Merck KGaA)
    90
    Merck KGaA 1:100 mouse anti-human β6 integrin subunit antibody
    Analysis of αVβ6 expression. ( A ) ITGB6 proteomic expression profile in normal tissue and primary tumor (data from UALCAN) ( n = 71–108; *** p < 0.001; Two sample t test). ( B ) RT-qPCR analysis of ITGB6 mRNA expression; β-actin was used as housekeeping gene. The (αVβ6+) cell line HT-29 was used as reference ( n = 3–8; *** p < 0.001; One-way ANOVA followed by Tukey’s assay). ( C - D ) <t>β6</t> <t>integrin</t> subunit protein expression assessed by Western-Blot; tubulin was used as a loading control ( n = 3–7; *** p < 0.001; One way ANOVA followed by Tukey’s assay). Data are presented as mean ± SEM
    1:100 Mouse Anti Human β6 Integrin Subunit Antibody, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/1:100 mouse anti-human β6 integrin subunit antibody/product/Merck KGaA
    Average 90 stars, based on 1 article reviews
    1:100 mouse anti-human β6 integrin subunit antibody - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    β6 integrin subunit  (R&D Systems)
    92
    R&D Systems β6 integrin subunit
    (A) Immunoblotting (IB) analysis of total cell lysates (TCL) from PC3 cells containing the <t>β6</t> <t>integrin</t> subunit, PC3-WT not treated with siRNA (−), PC3 cells treated with non-silencing siRNA (NS), or the β6 integrin subunit siRNA (D2) (30 µg). TCL were separated using 12.5% SDS–PAGE. TCL were examined for the expression of the β6 integrin subunit (left panel, non-reducing SDS–PAGE), IFIT3 and STAT1 (right panel, reducing SDS–PAGE). TSG101 (left panel, non-reducing SDS–PAGE) and Actin (right panel, reducing SDS–PAGE) were used as protein loading controls. (B) IB analysis of TCL from PC3-WT cells and PC3-CRISPR clones devoid of the β6 integrin subunit, β6KO C5 and C7 (30 µg). TCL were separated using 12.5% SDS–PAGE. TCL were examined for the expression of the β6 integrin subunit (left panel, non-reducing SDS–PAGE), IFIT3 and STAT1 (right panel, reducing SDS–PAGE). The Actin membrane (right panel, reducing SDS–PAGE) was stripped to visualize IFIT3. Actin (left panel, non-reducing SDS–PAGE), and (right panel, reducing SDS–PAGE) was used as a protein loading control.
    β6 Integrin Subunit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/β6 integrin subunit/product/R&D Systems
    Average 92 stars, based on 1 article reviews
    β6 integrin subunit - by Bioz Stars, 2026-05
    92/100 stars
    		  Buy from Supplier
    mouse monoclonal abs against the human β6 integrin subunit (6.2a1) antibody  (Santa Cruz Biotechnology)
    90
    Santa Cruz Biotechnology mouse monoclonal abs against the human β6 integrin subunit (6.2a1) antibody
    (A) Immunoblotting (IB) analysis of total cell lysates (TCL) from PC3 cells containing the <t>β6</t> <t>integrin</t> subunit, PC3-WT not treated with siRNA (−), PC3 cells treated with non-silencing siRNA (NS), or the β6 integrin subunit siRNA (D2) (30 µg). TCL were separated using 12.5% SDS–PAGE. TCL were examined for the expression of the β6 integrin subunit (left panel, non-reducing SDS–PAGE), IFIT3 and STAT1 (right panel, reducing SDS–PAGE). TSG101 (left panel, non-reducing SDS–PAGE) and Actin (right panel, reducing SDS–PAGE) were used as protein loading controls. (B) IB analysis of TCL from PC3-WT cells and PC3-CRISPR clones devoid of the β6 integrin subunit, β6KO C5 and C7 (30 µg). TCL were separated using 12.5% SDS–PAGE. TCL were examined for the expression of the β6 integrin subunit (left panel, non-reducing SDS–PAGE), IFIT3 and STAT1 (right panel, reducing SDS–PAGE). The Actin membrane (right panel, reducing SDS–PAGE) was stripped to visualize IFIT3. Actin (left panel, non-reducing SDS–PAGE), and (right panel, reducing SDS–PAGE) was used as a protein loading control.
    Mouse Monoclonal Abs Against The Human β6 Integrin Subunit (6.2a1) Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse monoclonal abs against the human β6 integrin subunit (6.2a1) antibody/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    mouse monoclonal abs against the human β6 integrin subunit (6.2a1) antibody - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    mab against the β6 subunit of the human αvβ6 integrin clone 6.4b4 antibody  (Biogen Inc)
    90
    Biogen Inc mab against the β6 subunit of the human αvβ6 integrin clone 6.4b4 antibody
    (A) Immunoblotting (IB) analysis of total cell lysates (TCL) from PC3 cells containing the <t>β6</t> <t>integrin</t> subunit, PC3-WT not treated with siRNA (−), PC3 cells treated with non-silencing siRNA (NS), or the β6 integrin subunit siRNA (D2) (30 µg). TCL were separated using 12.5% SDS–PAGE. TCL were examined for the expression of the β6 integrin subunit (left panel, non-reducing SDS–PAGE), IFIT3 and STAT1 (right panel, reducing SDS–PAGE). TSG101 (left panel, non-reducing SDS–PAGE) and Actin (right panel, reducing SDS–PAGE) were used as protein loading controls. (B) IB analysis of TCL from PC3-WT cells and PC3-CRISPR clones devoid of the β6 integrin subunit, β6KO C5 and C7 (30 µg). TCL were separated using 12.5% SDS–PAGE. TCL were examined for the expression of the β6 integrin subunit (left panel, non-reducing SDS–PAGE), IFIT3 and STAT1 (right panel, reducing SDS–PAGE). The Actin membrane (right panel, reducing SDS–PAGE) was stripped to visualize IFIT3. Actin (left panel, non-reducing SDS–PAGE), and (right panel, reducing SDS–PAGE) was used as a protein loading control.
    Mab Against The β6 Subunit Of The Human αvβ6 Integrin Clone 6.4b4 Antibody, supplied by Biogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mab against the β6 subunit of the human αvβ6 integrin clone 6.4b4 antibody/product/Biogen Inc
    Average 90 stars, based on 1 article reviews
    mab against the β6 subunit of the human αvβ6 integrin clone 6.4b4 antibody - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Analysis of αVβ6 expression. ( A ) ITGB6 proteomic expression profile in normal tissue and primary tumor (data from UALCAN) ( n = 71–108; *** p < 0.001; Two sample t test). ( B ) RT-qPCR analysis of ITGB6 mRNA expression; β-actin was used as housekeeping gene. The (αVβ6+) cell line HT-29 was used as reference ( n = 3–8; *** p < 0.001; One-way ANOVA followed by Tukey’s assay). ( C - D ) β6 integrin subunit protein expression assessed by Western-Blot; tubulin was used as a loading control ( n = 3–7; *** p < 0.001; One way ANOVA followed by Tukey’s assay). Data are presented as mean ± SEM

    Journal: Cancer Cell International

    Article Title: Targeting of 3D oral cancer spheroids by αVβ6 integrin using near-infrared peptide-conjugated IRDye 680

    doi: 10.1186/s12935-024-03417-y

    Figure Lengend Snippet: Analysis of αVβ6 expression. ( A ) ITGB6 proteomic expression profile in normal tissue and primary tumor (data from UALCAN) ( n = 71–108; *** p < 0.001; Two sample t test). ( B ) RT-qPCR analysis of ITGB6 mRNA expression; β-actin was used as housekeeping gene. The (αVβ6+) cell line HT-29 was used as reference ( n = 3–8; *** p < 0.001; One-way ANOVA followed by Tukey’s assay). ( C - D ) β6 integrin subunit protein expression assessed by Western-Blot; tubulin was used as a loading control ( n = 3–7; *** p < 0.001; One way ANOVA followed by Tukey’s assay). Data are presented as mean ± SEM

    Article Snippet: 40 µg of protein lysate was loaded to 7.5% non-reducing SDS PAGE and after 150 min of migration and 90 min of blotting, PVDF membrane was saturated with 5% (w/v) solution of non-fat powered milk in TBST (Tris buffer solution with 0.1% Tween-20) for 1 h. Membrane was incubated overnight at 4 °C with either 1:100 mouse anti-human β6 integrin subunit antibody (Merck Millipore corp, USA, 407,317) or 1:1000 mouse anti-α-tubulin antibody (Santa Cruz Biotechnology, 23,948), followed by incubation with 1:2000 anti-mouse IgG HRP-conjugated secondary antibody (Cell signaling technology, 7076 S) for 1 h at room temperature.

    Techniques: Expressing, Quantitative RT-PCR, Western Blot, Control

    Multicellular tumor spheroid characterization. ( A ) Typical cryosection images of H10 and H5M5 spheroids after KI-67 immunohistochemistry staining (scale bar = 150 μm). ( B ) Typical immunofluorescence images of H10 and H5M5 spheroids cryosections stained with antibodies against αVβ6 integrin, cytokeratin 19, E-cadherin, vimentin, and fibronectin at day 4 post-seeding. Proteins of interest are in red and nuclei are in bleu after counterstaining with Vectashield-DAPI (scale bar = 100 μm at x40 and 40 μm at x100). ( C ) Relative quantification of immunofluorescence markers expression using ImageJ software ( n = 3–4; * p < 0.05, ** p < 0.01; Two sample t test). Data are presented as mean ± SEM

    Journal: Cancer Cell International

    Article Title: Targeting of 3D oral cancer spheroids by αVβ6 integrin using near-infrared peptide-conjugated IRDye 680

    doi: 10.1186/s12935-024-03417-y

    Figure Lengend Snippet: Multicellular tumor spheroid characterization. ( A ) Typical cryosection images of H10 and H5M5 spheroids after KI-67 immunohistochemistry staining (scale bar = 150 μm). ( B ) Typical immunofluorescence images of H10 and H5M5 spheroids cryosections stained with antibodies against αVβ6 integrin, cytokeratin 19, E-cadherin, vimentin, and fibronectin at day 4 post-seeding. Proteins of interest are in red and nuclei are in bleu after counterstaining with Vectashield-DAPI (scale bar = 100 μm at x40 and 40 μm at x100). ( C ) Relative quantification of immunofluorescence markers expression using ImageJ software ( n = 3–4; * p < 0.05, ** p < 0.01; Two sample t test). Data are presented as mean ± SEM

    Article Snippet: 40 µg of protein lysate was loaded to 7.5% non-reducing SDS PAGE and after 150 min of migration and 90 min of blotting, PVDF membrane was saturated with 5% (w/v) solution of non-fat powered milk in TBST (Tris buffer solution with 0.1% Tween-20) for 1 h. Membrane was incubated overnight at 4 °C with either 1:100 mouse anti-human β6 integrin subunit antibody (Merck Millipore corp, USA, 407,317) or 1:1000 mouse anti-α-tubulin antibody (Santa Cruz Biotechnology, 23,948), followed by incubation with 1:2000 anti-mouse IgG HRP-conjugated secondary antibody (Cell signaling technology, 7076 S) for 1 h at room temperature.

    Techniques: Immunohistochemistry, Staining, Immunofluorescence, Expressing, Software

    (A) Immunoblotting (IB) analysis of total cell lysates (TCL) from PC3 cells containing the β6 integrin subunit, PC3-WT not treated with siRNA (−), PC3 cells treated with non-silencing siRNA (NS), or the β6 integrin subunit siRNA (D2) (30 µg). TCL were separated using 12.5% SDS–PAGE. TCL were examined for the expression of the β6 integrin subunit (left panel, non-reducing SDS–PAGE), IFIT3 and STAT1 (right panel, reducing SDS–PAGE). TSG101 (left panel, non-reducing SDS–PAGE) and Actin (right panel, reducing SDS–PAGE) were used as protein loading controls. (B) IB analysis of TCL from PC3-WT cells and PC3-CRISPR clones devoid of the β6 integrin subunit, β6KO C5 and C7 (30 µg). TCL were separated using 12.5% SDS–PAGE. TCL were examined for the expression of the β6 integrin subunit (left panel, non-reducing SDS–PAGE), IFIT3 and STAT1 (right panel, reducing SDS–PAGE). The Actin membrane (right panel, reducing SDS–PAGE) was stripped to visualize IFIT3. Actin (left panel, non-reducing SDS–PAGE), and (right panel, reducing SDS–PAGE) was used as a protein loading control.

    Journal: The Biochemical journal

    Article Title: IFIT3 (Interferon Induced Protein with Tetratricopeptide Repeats 3) Modulates STAT1 Expression in small Extracellular Vesicles

    doi: 10.1042/BCJ20210580

    Figure Lengend Snippet: (A) Immunoblotting (IB) analysis of total cell lysates (TCL) from PC3 cells containing the β6 integrin subunit, PC3-WT not treated with siRNA (−), PC3 cells treated with non-silencing siRNA (NS), or the β6 integrin subunit siRNA (D2) (30 µg). TCL were separated using 12.5% SDS–PAGE. TCL were examined for the expression of the β6 integrin subunit (left panel, non-reducing SDS–PAGE), IFIT3 and STAT1 (right panel, reducing SDS–PAGE). TSG101 (left panel, non-reducing SDS–PAGE) and Actin (right panel, reducing SDS–PAGE) were used as protein loading controls. (B) IB analysis of TCL from PC3-WT cells and PC3-CRISPR clones devoid of the β6 integrin subunit, β6KO C5 and C7 (30 µg). TCL were separated using 12.5% SDS–PAGE. TCL were examined for the expression of the β6 integrin subunit (left panel, non-reducing SDS–PAGE), IFIT3 and STAT1 (right panel, reducing SDS–PAGE). The Actin membrane (right panel, reducing SDS–PAGE) was stripped to visualize IFIT3. Actin (left panel, non-reducing SDS–PAGE), and (right panel, reducing SDS–PAGE) was used as a protein loading control.

    Article Snippet: The following Abs were used for IB analyses: mouse monoclonal Abs against the human β6 integrin subunit (6.2A1) [ 34 ], CD9 (Santa Cruz, sc-13118), CD63 (Abcam, ab8219), CD81 (Abcam, ab23505), STAT1 (Santa Cruz, sc-271661) and IFIT3 (Santa Cruz, sc-393512); rabbit polyclonal Abs against Actin (Sigma–Aldrich, A2066) and calnexin (Cell signaling, 2433S); rabbit monoclonal TSG101 (Abcam, ab125011); and goat-affinity purified polyclonal Abs against the β6 integrin subunit (R&D Systems, AF2389).

    Techniques: Western Blot, SDS Page, Expressing, CRISPR, Clone Assay, Membrane, Control

    (A) IB analysis of sEV fractions (F1-F10) isolated via iodixanol density gradients and derived from PC3 wild-type (PC3-WT) cells containing the β6 integrin subunit, (PC3-WT). PC3-WT TCL (20 µg), PC3-WT (PC3-WT 100K) sEV lysate (10 µg) and PC3-WT sEV fraction lysates were separated using 12.5% SDS–PAGE. Comparable volumes of each sEV fraction were loaded (30 µl). The 10 consecutive sEV fractions have densities of 1.103, 1.117,1.134,1.151, 1.169, 1.186, 1.193, 1.193, 1.200, and 1.207 g/ml, respectively. Expression of the β6 integrin subunit, CD63, CD81 (left panel, non-reducing SDS–PAGE) as well as STAT1, IFIT3 and CD9 (right panel, reducing SDS–PAGE) was analyzed in sEV fractions 1 to 10. The STAT1 membrane (right panel, reducing SDS–PAGE) was stripped to visualize calnexin (CNX). CNX (right panel, reducing SDS–PAGE) in PC3-β6KO C7, PC3-WT TCL, PC3-WT 100K as well as 10 consecutive PC3-WT derived sEV fractions was analyzed. PC3-WT 100K lysate was the input for the density gradient. (B) IB analysis of PC3-β6KO C7 derived sEV fractions isolated via density gradients. Total lysates (TCL 20 µg) from PC3-WT cells containing the β6 integrin subunit, as well as the PC3-CRISPR clone devoid of the β6 integrin subunit, PC3-β6KO C7, and PC3-β6KO C7 sEV fraction lysates were separated using 12.5% SDS–PAGE. Comparable volumes of each sEV fraction were loaded (30 µl). The 10 consecutive sEV fractions have densities of 1.075, 1.099, 1.123, 1.134, 1.151, 1.165, 1.169, 1.182, 1.186, and 1.193 g/ml, respectively. Expression of the β6 integrin, CD63, CD81 (left panel, non-reducing SDS–PAGE), STAT1, IFIT3 and CD9 (right panel, reducing SDS–PAGE) was analyzed in sEV fractions 1 to 10. The STAT1 membrane (right panel, reducing SDS–PAGE) was stripped to visualize calnexin (CNX). CNX (right panel, reducing SDS–PAGE) in the PC3-CRISPR clone lacking the β6 integrin subunit, PC3-β6KO C7 TCL and PC3-β6KO C7 derived sEV fractions was analyzed. A and B, TCL = total cell lysates.

    Journal: The Biochemical journal

    Article Title: IFIT3 (Interferon Induced Protein with Tetratricopeptide Repeats 3) Modulates STAT1 Expression in small Extracellular Vesicles

    doi: 10.1042/BCJ20210580

    Figure Lengend Snippet: (A) IB analysis of sEV fractions (F1-F10) isolated via iodixanol density gradients and derived from PC3 wild-type (PC3-WT) cells containing the β6 integrin subunit, (PC3-WT). PC3-WT TCL (20 µg), PC3-WT (PC3-WT 100K) sEV lysate (10 µg) and PC3-WT sEV fraction lysates were separated using 12.5% SDS–PAGE. Comparable volumes of each sEV fraction were loaded (30 µl). The 10 consecutive sEV fractions have densities of 1.103, 1.117,1.134,1.151, 1.169, 1.186, 1.193, 1.193, 1.200, and 1.207 g/ml, respectively. Expression of the β6 integrin subunit, CD63, CD81 (left panel, non-reducing SDS–PAGE) as well as STAT1, IFIT3 and CD9 (right panel, reducing SDS–PAGE) was analyzed in sEV fractions 1 to 10. The STAT1 membrane (right panel, reducing SDS–PAGE) was stripped to visualize calnexin (CNX). CNX (right panel, reducing SDS–PAGE) in PC3-β6KO C7, PC3-WT TCL, PC3-WT 100K as well as 10 consecutive PC3-WT derived sEV fractions was analyzed. PC3-WT 100K lysate was the input for the density gradient. (B) IB analysis of PC3-β6KO C7 derived sEV fractions isolated via density gradients. Total lysates (TCL 20 µg) from PC3-WT cells containing the β6 integrin subunit, as well as the PC3-CRISPR clone devoid of the β6 integrin subunit, PC3-β6KO C7, and PC3-β6KO C7 sEV fraction lysates were separated using 12.5% SDS–PAGE. Comparable volumes of each sEV fraction were loaded (30 µl). The 10 consecutive sEV fractions have densities of 1.075, 1.099, 1.123, 1.134, 1.151, 1.165, 1.169, 1.182, 1.186, and 1.193 g/ml, respectively. Expression of the β6 integrin, CD63, CD81 (left panel, non-reducing SDS–PAGE), STAT1, IFIT3 and CD9 (right panel, reducing SDS–PAGE) was analyzed in sEV fractions 1 to 10. The STAT1 membrane (right panel, reducing SDS–PAGE) was stripped to visualize calnexin (CNX). CNX (right panel, reducing SDS–PAGE) in the PC3-CRISPR clone lacking the β6 integrin subunit, PC3-β6KO C7 TCL and PC3-β6KO C7 derived sEV fractions was analyzed. A and B, TCL = total cell lysates.

    Article Snippet: The following Abs were used for IB analyses: mouse monoclonal Abs against the human β6 integrin subunit (6.2A1) [ 34 ], CD9 (Santa Cruz, sc-13118), CD63 (Abcam, ab8219), CD81 (Abcam, ab23505), STAT1 (Santa Cruz, sc-271661) and IFIT3 (Santa Cruz, sc-393512); rabbit polyclonal Abs against Actin (Sigma–Aldrich, A2066) and calnexin (Cell signaling, 2433S); rabbit monoclonal TSG101 (Abcam, ab125011); and goat-affinity purified polyclonal Abs against the β6 integrin subunit (R&D Systems, AF2389).

    Techniques: Isolation, Derivative Assay, SDS Page, Expressing, Membrane, CRISPR

    (A) Nanoparticle tracking analysis (NTA) measurement of size distribution and concentration of sEV fractions 2 to 5 derived from cells containing the β6 integrin subunit (PC3-WT). (B) NTA measurement of size distribution and concentration of sEV fractions 2 to 5 derived from the PC3-CRISPR clone devoid of the β6 integrin subunit, PC3-β6KO C7.

    Journal: The Biochemical journal

    Article Title: IFIT3 (Interferon Induced Protein with Tetratricopeptide Repeats 3) Modulates STAT1 Expression in small Extracellular Vesicles

    doi: 10.1042/BCJ20210580

    Figure Lengend Snippet: (A) Nanoparticle tracking analysis (NTA) measurement of size distribution and concentration of sEV fractions 2 to 5 derived from cells containing the β6 integrin subunit (PC3-WT). (B) NTA measurement of size distribution and concentration of sEV fractions 2 to 5 derived from the PC3-CRISPR clone devoid of the β6 integrin subunit, PC3-β6KO C7.

    Article Snippet: The following Abs were used for IB analyses: mouse monoclonal Abs against the human β6 integrin subunit (6.2A1) [ 34 ], CD9 (Santa Cruz, sc-13118), CD63 (Abcam, ab8219), CD81 (Abcam, ab23505), STAT1 (Santa Cruz, sc-271661) and IFIT3 (Santa Cruz, sc-393512); rabbit polyclonal Abs against Actin (Sigma–Aldrich, A2066) and calnexin (Cell signaling, 2433S); rabbit monoclonal TSG101 (Abcam, ab125011); and goat-affinity purified polyclonal Abs against the β6 integrin subunit (R&D Systems, AF2389).

    Techniques: Concentration Assay, Derivative Assay, CRISPR

    (A) NTA measurement of size distribution and concentration of density gradient-isolated sEVs (pooled fractions 2 to 5) derived from cells containing the β6 integrin subunit, PC3-CRISPR control and the PC3-CRISPR clones devoid of the β6 integrin subunit, β6KO C5 and β6KO C7. (B) Transmission electron microscopy analysis of density gradient-isolated sEVs (pooled fractions 2 to 5) derived from PC3-CRISPR control and β6KO C5 cells. Scale bar = 100 nm.

    Journal: The Biochemical journal

    Article Title: IFIT3 (Interferon Induced Protein with Tetratricopeptide Repeats 3) Modulates STAT1 Expression in small Extracellular Vesicles

    doi: 10.1042/BCJ20210580

    Figure Lengend Snippet: (A) NTA measurement of size distribution and concentration of density gradient-isolated sEVs (pooled fractions 2 to 5) derived from cells containing the β6 integrin subunit, PC3-CRISPR control and the PC3-CRISPR clones devoid of the β6 integrin subunit, β6KO C5 and β6KO C7. (B) Transmission electron microscopy analysis of density gradient-isolated sEVs (pooled fractions 2 to 5) derived from PC3-CRISPR control and β6KO C5 cells. Scale bar = 100 nm.

    Article Snippet: The following Abs were used for IB analyses: mouse monoclonal Abs against the human β6 integrin subunit (6.2A1) [ 34 ], CD9 (Santa Cruz, sc-13118), CD63 (Abcam, ab8219), CD81 (Abcam, ab23505), STAT1 (Santa Cruz, sc-271661) and IFIT3 (Santa Cruz, sc-393512); rabbit polyclonal Abs against Actin (Sigma–Aldrich, A2066) and calnexin (Cell signaling, 2433S); rabbit monoclonal TSG101 (Abcam, ab125011); and goat-affinity purified polyclonal Abs against the β6 integrin subunit (R&D Systems, AF2389).

    Techniques: Concentration Assay, Isolation, Derivative Assay, CRISPR, Control, Clone Assay, Transmission Assay, Electron Microscopy

    (A) IB analysis of PC3-WT and the PC3-CRISPR clones devoid of IFIT3: PC3-IFIT3KO C13 and PC3-IFIT3KO C15 TCL (total cell lysates) (30 µg). TCL were separated using 12.5% SDS–PAGE and examined for the expression of STAT1 and IFIT3 (reducing SDS–PAGE). The IFIT3 membrane (reducing SDS–PAGE) was stripped to visualize Actin. Actin (reducing SDS–PAGE) was used as a protein loading control. Dark and light exposures shown (Top and bottom, respectively). (B) IB analysis of cells expressing the β6 integrin subunit, PC3-CRISPR control cell-derived sEV fractions isolated via density gradients. PC3-CRISPR control TCL (20 µg), PC3-CRISPR control (CRISPR control 100K) sEV lysate (10 µg), and PC3-CRISPR control sEV fraction lysates were separated by using 12.5% SDS–PAGE. Comparable volumes of each sEV fraction were loaded (30 µl). The 10 consecutive sEV fractions have a density of 1.099, 1.113,1.123,1.137, 1.148, 1.162, 1.179, 1.186, 1.193, and 1.210 g/ml, respectively. Expression of the β6 integrin subunit, CD63, CD81 (left panel, non-reducing SDS–PAGE), STAT1, IFIT3, TSG101 and CD9 (right panel, reducing SDS–PAGE) was analyzed in sEV fractions 1 to 10. IFIT3 (right panel, reducing SDS–PAGE) and STAT1 membranes (right panel, reducing SDS–PAGE) were stripped to visualize TSG101 and calnexin (CNX), respectively. CNX expression (right panel, reducing SDS–PAGE) in PC3-CRISPR control TCL, CRISPR control 100K as well as 10 consecutive PC3-CRISPR control cell-derived sEV fractions is shown. CRISPR control 100K sEV lysate was used as input for the density gradient. (C) IB analysis of sEV fractions derived from a PC3-CRISPR clone devoid of IFIT3, designated as PC3-IFIT3KO C13, and isolated via density gradients. PC3-IFIT3KO C13 TCL (20 µg), PC3-IFIT3KO C13 (IFIT3KO C13 100K) sEV lysate (10 µg) and PC3-IFIT3KO C13 sEV fraction lysates were separated using 12.5% SDS–PAGE. Comparable volumes of each sEV fraction were loaded (30 µl). The 10 consecutive sEV fractions have a density of 1.106, 1.110,1.130,1.134, 1.155, 1.169, 1.175, 1.182, 1.182, and 1.189 g/ml, respectively. Expression of the β6 integrin subunit, CD63 and CD81 (left panel, non-reducing SDS–PAGE) is analyzed in sEV fractions 1 to 10. The β6 integrin subunit membrane (left panel, reducing SDS–PAGE) was stripped to visualize calnexin (CNX). CNX expression (left panel, non-reducing SDS–PAGE) in PC3-IFIT3KO C13 TCL, PC3-WT 100K, IFIT3 C13 100K and 10 consecutive PC3-IFIT3KO C13 cell-derived sEV fractions is shown. Expression of STAT1, TSG101 and CD9 (right panel, reducing SDS–PAGE) is analyzed. IFIT3KO C13 100K was the input for the density gradient.

    Journal: The Biochemical journal

    Article Title: IFIT3 (Interferon Induced Protein with Tetratricopeptide Repeats 3) Modulates STAT1 Expression in small Extracellular Vesicles

    doi: 10.1042/BCJ20210580

    Figure Lengend Snippet: (A) IB analysis of PC3-WT and the PC3-CRISPR clones devoid of IFIT3: PC3-IFIT3KO C13 and PC3-IFIT3KO C15 TCL (total cell lysates) (30 µg). TCL were separated using 12.5% SDS–PAGE and examined for the expression of STAT1 and IFIT3 (reducing SDS–PAGE). The IFIT3 membrane (reducing SDS–PAGE) was stripped to visualize Actin. Actin (reducing SDS–PAGE) was used as a protein loading control. Dark and light exposures shown (Top and bottom, respectively). (B) IB analysis of cells expressing the β6 integrin subunit, PC3-CRISPR control cell-derived sEV fractions isolated via density gradients. PC3-CRISPR control TCL (20 µg), PC3-CRISPR control (CRISPR control 100K) sEV lysate (10 µg), and PC3-CRISPR control sEV fraction lysates were separated by using 12.5% SDS–PAGE. Comparable volumes of each sEV fraction were loaded (30 µl). The 10 consecutive sEV fractions have a density of 1.099, 1.113,1.123,1.137, 1.148, 1.162, 1.179, 1.186, 1.193, and 1.210 g/ml, respectively. Expression of the β6 integrin subunit, CD63, CD81 (left panel, non-reducing SDS–PAGE), STAT1, IFIT3, TSG101 and CD9 (right panel, reducing SDS–PAGE) was analyzed in sEV fractions 1 to 10. IFIT3 (right panel, reducing SDS–PAGE) and STAT1 membranes (right panel, reducing SDS–PAGE) were stripped to visualize TSG101 and calnexin (CNX), respectively. CNX expression (right panel, reducing SDS–PAGE) in PC3-CRISPR control TCL, CRISPR control 100K as well as 10 consecutive PC3-CRISPR control cell-derived sEV fractions is shown. CRISPR control 100K sEV lysate was used as input for the density gradient. (C) IB analysis of sEV fractions derived from a PC3-CRISPR clone devoid of IFIT3, designated as PC3-IFIT3KO C13, and isolated via density gradients. PC3-IFIT3KO C13 TCL (20 µg), PC3-IFIT3KO C13 (IFIT3KO C13 100K) sEV lysate (10 µg) and PC3-IFIT3KO C13 sEV fraction lysates were separated using 12.5% SDS–PAGE. Comparable volumes of each sEV fraction were loaded (30 µl). The 10 consecutive sEV fractions have a density of 1.106, 1.110,1.130,1.134, 1.155, 1.169, 1.175, 1.182, 1.182, and 1.189 g/ml, respectively. Expression of the β6 integrin subunit, CD63 and CD81 (left panel, non-reducing SDS–PAGE) is analyzed in sEV fractions 1 to 10. The β6 integrin subunit membrane (left panel, reducing SDS–PAGE) was stripped to visualize calnexin (CNX). CNX expression (left panel, non-reducing SDS–PAGE) in PC3-IFIT3KO C13 TCL, PC3-WT 100K, IFIT3 C13 100K and 10 consecutive PC3-IFIT3KO C13 cell-derived sEV fractions is shown. Expression of STAT1, TSG101 and CD9 (right panel, reducing SDS–PAGE) is analyzed. IFIT3KO C13 100K was the input for the density gradient.

    Article Snippet: The following Abs were used for IB analyses: mouse monoclonal Abs against the human β6 integrin subunit (6.2A1) [ 34 ], CD9 (Santa Cruz, sc-13118), CD63 (Abcam, ab8219), CD81 (Abcam, ab23505), STAT1 (Santa Cruz, sc-271661) and IFIT3 (Santa Cruz, sc-393512); rabbit polyclonal Abs against Actin (Sigma–Aldrich, A2066) and calnexin (Cell signaling, 2433S); rabbit monoclonal TSG101 (Abcam, ab125011); and goat-affinity purified polyclonal Abs against the β6 integrin subunit (R&D Systems, AF2389).

    Techniques: CRISPR, Clone Assay, SDS Page, Expressing, Membrane, Control, Derivative Assay, Isolation

    (A) IB analysis of PC3-CRISPR control cells and PC3-CRISPR clones devoid of STAT1, PC3-STAT1KO C21 as well as PC3-STAT1KO C1C5 TCL (total cell lysates) (30 µg). TCL were separated using 12.5% SDS–PAGE. TCL were examined for the expression of STAT1, IFIT3, and Actin (reducing SDS–PAGE). The IFIT3 membrane (reducing SDS–PAGE) was stripped to visualize Actin. Actin was used as a protein loading control. (B) NTA measurement of size distribution and concentration of PC3-STAT1KO C21 derived sEV fractions 2-5. (C) IB analysis of sEV fractions derived from a PC3-CRISPR clone lacking STAT1, designated as PC3-STAT1KO C21, and isolated via density gradients. PC3-β6KO C7, PC3-STAT1KO C21 TCL (20 µg), PC3-STAT1KO C21 (STAT1KO C21 100K) sEV lysate (10 µg) and PC3-STAT1KO C21 sEV fraction lysates were separated by using 12.5% SDS–PAGE. Comparable volumes of each sEV fraction were loaded (30 µl). The 10 consecutive sEV fractions have a density of 1.106, 1.123,1.127,1.144 1.165, 1.169,1.186, 1.193, 1.200, and 1.207 g/ml, respectively. Expression of STAT1, IFIT3, TSG101, CD9 and CD81 (reducing SDS–PAGE) was analyzed in sEV fractions 1 to 10. The IFIT3, STAT1 and CD9 membranes (reducing SDS–PAGE) were stripped to visualize TSG101, calnexin (CNX), and CD81 respectively. CNX expression (reducing SDS–PAGE) was analyzed in PC3-CRISPR clone devoid of the β6 integrin subunit, PC3-β6KO C7 as well as PC3-CRISPR clone lacking STAT1, PC3-STAT1KO C21 TCL, STAT1KO C21 100K and 10 consecutive PC3-STAT1KO C21 derived sEV fractions. PC3-STAT1KO C21 100K sEV lysate was used as input for the density gradient.

    Journal: The Biochemical journal

    Article Title: IFIT3 (Interferon Induced Protein with Tetratricopeptide Repeats 3) Modulates STAT1 Expression in small Extracellular Vesicles

    doi: 10.1042/BCJ20210580

    Figure Lengend Snippet: (A) IB analysis of PC3-CRISPR control cells and PC3-CRISPR clones devoid of STAT1, PC3-STAT1KO C21 as well as PC3-STAT1KO C1C5 TCL (total cell lysates) (30 µg). TCL were separated using 12.5% SDS–PAGE. TCL were examined for the expression of STAT1, IFIT3, and Actin (reducing SDS–PAGE). The IFIT3 membrane (reducing SDS–PAGE) was stripped to visualize Actin. Actin was used as a protein loading control. (B) NTA measurement of size distribution and concentration of PC3-STAT1KO C21 derived sEV fractions 2-5. (C) IB analysis of sEV fractions derived from a PC3-CRISPR clone lacking STAT1, designated as PC3-STAT1KO C21, and isolated via density gradients. PC3-β6KO C7, PC3-STAT1KO C21 TCL (20 µg), PC3-STAT1KO C21 (STAT1KO C21 100K) sEV lysate (10 µg) and PC3-STAT1KO C21 sEV fraction lysates were separated by using 12.5% SDS–PAGE. Comparable volumes of each sEV fraction were loaded (30 µl). The 10 consecutive sEV fractions have a density of 1.106, 1.123,1.127,1.144 1.165, 1.169,1.186, 1.193, 1.200, and 1.207 g/ml, respectively. Expression of STAT1, IFIT3, TSG101, CD9 and CD81 (reducing SDS–PAGE) was analyzed in sEV fractions 1 to 10. The IFIT3, STAT1 and CD9 membranes (reducing SDS–PAGE) were stripped to visualize TSG101, calnexin (CNX), and CD81 respectively. CNX expression (reducing SDS–PAGE) was analyzed in PC3-CRISPR clone devoid of the β6 integrin subunit, PC3-β6KO C7 as well as PC3-CRISPR clone lacking STAT1, PC3-STAT1KO C21 TCL, STAT1KO C21 100K and 10 consecutive PC3-STAT1KO C21 derived sEV fractions. PC3-STAT1KO C21 100K sEV lysate was used as input for the density gradient.

    Article Snippet: The following Abs were used for IB analyses: mouse monoclonal Abs against the human β6 integrin subunit (6.2A1) [ 34 ], CD9 (Santa Cruz, sc-13118), CD63 (Abcam, ab8219), CD81 (Abcam, ab23505), STAT1 (Santa Cruz, sc-271661) and IFIT3 (Santa Cruz, sc-393512); rabbit polyclonal Abs against Actin (Sigma–Aldrich, A2066) and calnexin (Cell signaling, 2433S); rabbit monoclonal TSG101 (Abcam, ab125011); and goat-affinity purified polyclonal Abs against the β6 integrin subunit (R&D Systems, AF2389).

    Techniques: CRISPR, Control, Clone Assay, SDS Page, Expressing, Membrane, Concentration Assay, Derivative Assay, Isolation